RA Capital Management Q2 2018

RA Capital Management holdings Q2 2018
Name ValueChangeSharesChangeWeightingChange
WAVE LIFE SCIENCES LTD$287,336
-4.61%
7,512,0490.00%18.66%
-19.17%
ASCENDIS PHARMA A Ssponsored adr$282,080
1.71%
4,240,5360.00%18.31%
-13.81%
SOLID BIOSCIENCES INC$95,825
375.06%
2,689,4440.00%6.22%
302.57%
ENDOCYTE INC$77,968
120.97%
5,649,884
45.55%
5.06%
87.25%
MOMENTA PHARMACEUTICALS INCNew $75,7173,702,5334.92%
IMMUNOMEDICS INCNew $73,8453,119,7784.79%
MYOVANT SCIENCES LTD$64,733
7.52%
2,830,4550.00%4.20%
-8.89%
INFLARX NV$63,441
35.73%
1,967,148
21.38%
4.12%
15.02%
TG THERAPEUTICS INC$56,266
60.27%
4,278,796
73.07%
3.65%
35.81%
SAGE THERAPEUTICS INC$54,932
-3.42%
350,933
-0.62%
3.57%
-18.16%
ZOGENIX INC$50,621
10.36%
1,145,2680.00%3.29%
-6.48%
RHYTHM PHARMACEUTICALS INCNew $48,1951,541,7433.13%
DICERNA PHARMACEUTICALS INC$48,185
28.14%
3,933,4890.00%3.13%
8.58%
EIDOS THERAPEUTICS INCNew $43,9892,162,6712.86%
BIOCRYST PHARMACEUTICALS$40,022
20.12%
6,984,6920.00%2.60%
1.79%
RA PHARMACEUTICALS INC$38,325
87.38%
3,851,8080.00%2.49%
58.79%
KALA PHARMACEUTICALS INC$29,015
-13.27%
2,113,2360.00%1.88%
-26.50%
APELLIS PHARMACEUTICALS INC$19,800
-0.50%
900,0000.00%1.29%
-15.68%
CLEARSIDE BIOMEDICAL INC$16,302
-0.37%
1,525,0000.00%1.06%
-15.58%
SCPHARMACEUTICALS INC$16,171
-54.36%
2,857,1430.00%1.05%
-61.32%
IOVANCE BIOTHERAPEUTICS INC$14,351
28.85%
1,121,153
70.11%
0.93%
9.19%
KALVISTA PHARMACEUTICALS INC$11,701
-14.35%
1,441,0700.00%0.76%
-27.42%
AVEO PHARMACEUTICALS INC$11,442
-22.07%
5,062,7590.00%0.74%
-33.96%
SPERO THERAPEUTICS INC$10,880
2.95%
741,6470.00%0.71%
-12.76%
GLYCOMIMETICS INC$4,090
-0.61%
253,5470.00%0.27%
-15.77%
PROTEON THERAPEUTICS INC$3,277
-2.00%
1,337,4620.00%0.21%
-16.96%
G1 THERAPEUTICS INC$1,738
17.27%
40,0000.00%0.11%
-0.62%
BIOHAVEN PHARMACTL HLDG CO LTDSold $0-363,636-0.72%
CTI BIOPHARMA CORPSold $0-56,951-0.02%
CATALYST BIOSCIENCES INCSold $0-514,917-1.02%
AVEXIS INCSold $0-1,028,289-9.74%
SUNESIS PHARMACEUTICALS INCSold $0-2,471,456-0.52%
EDGE THERAPEUTICS INCSold $0-285,491-0.03%
VIKING THERAPEUTICS INCSold $0-2,029,396-0.68%
KRYSTAL BIOTECH INCSold $0-496,071-0.38%
Portfolio Information
QuarterQ2 2018
Total value$1,540,247,000
Holdings27
Managers
Peter Kolchinsky
Quarters
2018-06-30
$1,540,247
2018-03-31
$1,305,208
2017-12-31
$1,195,149
2017-09-30
$1,106,912
2017-06-30
$871,430
2017-03-31
$815,257
2016-12-31
$705,844
2016-09-30
$969,369
2016-06-30
$722,235
2016-03-31
$782,348
2015-12-31
$1,010,538
2015-09-30
$696,301
2015-06-30
$994,105
2015-03-31
$1,006,949
2014-12-31
$930,497
2014-09-30
$846,275
2014-06-30
$989,267
2014-03-31
$1,394,409
2013-12-31
$858,468
2013-09-30
$958,088
2013-06-30
$753,991
SEC Filings